Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology

PNKP TechnologyShown in Past Study to Increase Survival Rate in Colorectal Cancer Bearing Mice VANCOUVER, BC / ACCESS Newswire / April 17, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company")is …
Jetzt den vollständigen Artikel lesen